Thanks neoteric, I like that too and good to see them not going for a headline profit and saving on tax instead. Thats what I'd do with my own money so its what I want to see my companys doing too. strong, understated performance.
I must admit im not an expert on the sector and am trusting the company outlook, appreciate the warning to be vigilant as with the low liquidity It's not one youd want to have to dump in a hurry.
- Forums
- ASX - By Stock
- OCL
- Ann: FY2014 Appendix 4E and Financial Statements
Ann: FY2014 Appendix 4E and Financial Statements, page-4
Featured News
Add OCL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.54 |
Change
0.100(0.57%) |
Mkt cap ! $1.669B |
Open | High | Low | Value | Volume |
$17.43 | $17.70 | $17.25 | $1.105M | 63.17K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 68 | $17.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.54 | 163 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 68 | 17.500 |
2 | 843 | 17.450 |
2 | 183 | 17.410 |
2 | 439 | 17.390 |
1 | 183 | 17.370 |
Price($) | Vol. | No. |
---|---|---|
17.540 | 163 | 1 |
17.560 | 204 | 2 |
17.570 | 183 | 1 |
17.600 | 542 | 1 |
17.620 | 578 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
OCL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online